NICE guidelines for management of chest pain: Difference between revisions
Kiran Singh (talk | contribs) |
|||
Line 58: | Line 58: | ||
==NICE Guidelines for the Management of Patients with Acute Chest Pain (DO NOT EDIT)<ref name="pmid22420013">{{cite journal |author= |title= |journal=[[]] |volume= |issue= |pages= |year= |pmid=22420013 |doi= |url= |accessdate=2012-05-08}}</ref>== | ==NICE Guidelines for the Management of Patients with Acute Chest Pain (DO NOT EDIT)<ref name="pmid22420013">{{cite journal |author= |title= |journal=[[]] |volume= |issue= |pages= |year= |pmid=22420013 |doi= |url= |accessdate=2012-05-08}}</ref>== | ||
*'''[[NICE guidelines for the management of patients with acute chest pain]]''' | *'''[[NICE guidelines for the management of patients with acute chest pain]]''' | ||
==Investigation and diagnosis of acute [[chest pain]] in [[hospital]]== | |||
{{familytree/start}} | |||
{{familytree | | | | | | | | | A01 | | | | | |A01=Assessment of acute [[chest pain]] in hospital | |||
*Clinical [[history]] | |||
*[[Physical examination]] | |||
* Resting 12 leads [[ECG]] | |||
*[[hs-troponin]] on arrival | |||
*Risk stratification}} | |||
{{familytree | | |,|-|-|-|-|-|-|+|-|-|-|-|-|-|.| }} | |||
{{familytree | | B01 | | | | | B02 | | | | | B03 |B01=Normal resting [[ECG]] or non-diagnostic|B02= [[ECG]] changes consistent with [[NSTEMI]]|B03= [[ECG]] changes consistent with [[STEMI]]}} | |||
{{familytree |,|-|^|-|.| | | | |!| | | | | |!| | | |}} | |||
{{familytree | C1| |C2 | | |P1 | | | | G1| | | | | | | |C1= Low risk [[patient]] with undetectable [[hs-troponin]] level: Reassurance, discharge|P1=[[NSTEMI]], [[ACS]] Guideline follow-up|G1=[[STEMI]] Guideline follow-up|C2= Consider [[ACS]] by clinical judgment even in the presence of normal [[ECG]]<br> | |||
* Repeat [[hs-troponin]] level after 3 hours of arrival in hospital while diagnosis is not clear<br> | |||
* Serial [[ECG]] taken and clinically assessment of [[patient]] and considering [[the]] [[ECG]] changes<br> | |||
* Investigation regarding other life-threatening causes of [[chest pain]]<br> | |||
* NO need for routin non-invasive [[cardiac imaging]] or EX-[[ECG]] for initial evaluation | |||
* Consider other differential diagnosis<br> <br> | |||
* Consider hs-[[troponin]] level 3 hours after initiation of [[symptoms]]<br> | |||
* Consider an alternative diagnosis | |||
}} | |||
{{familytree| | | |,|-|^|-|.| | | |:| | | | | |:| | | | | | }} | |||
{{familytree| | |D1 | | |D2 |-|P2 |-|-|-|'| | | D1=hs-[[troponin]] concentration on arrival and at 3 hours bellow the cut-off measurement: Low risk [[patient]], discharge|D2=hs-[[troponin]] concentration on arrival and at 3 hours higher than cut-off measurement|P2= Diagnostic criteria for [[MI]] }} | |||
{{familytree| | | | | | | | | |,|-|^|-|.| | | | | | | | |}} | |||
{{familytree| | | | | | | | | P5| | |P6 | | | | | | | | |P5=Yes | |||
* Rise and fall in cardiac biomarker, especially hs-[[troponin]], with at least one of the following: | |||
*[[Symptoms]] of [[ischemia]] | |||
* Ischemic [[ECG]] changes including ST-T changes, new [[LBBB]], pathologic Q waves | |||
* [[Regional wall motion abnormalities]] on imaging study| P6=NO | |||
* Consider [[CXR]] or [[Chest CT scan]] for evaluation of alternative diagnosis}} | |||
{{familytree| | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree/end}} | |||
{| | |||
! colspan="2" style="background: PapayaWhip;" align="center" + |The above table adopted from 2016 NICE Guideline | |||
|- | |||
|} | |||
==NICE guidelines for the management of patients with stable chest pain (DO NOT EDIT)<ref name="pmid22420013">{{cite journal |author= |title= |journal=[[]] |volume= |issue= |pages= |year= |pmid=22420013 |doi= |url= |accessdate=2012-05-08}}</ref>== | ==NICE guidelines for the management of patients with stable chest pain (DO NOT EDIT)<ref name="pmid22420013">{{cite journal |author= |title= |journal=[[]] |volume= |issue= |pages= |year= |pmid=22420013 |doi= |url= |accessdate=2012-05-08}}</ref>== |
Revision as of 11:04, 7 January 2022
Chest pain Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
NICE guidelines for management of chest pain On the Web |
to Hospitals Treating NICE guidelines for management of chest pain |
Risk calculators and risk factors for NICE guidelines for management of chest pain |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Priyamvada Singh, M.B.B.S. [3]
Overview
The American College of Cardiology, American Heart Association,and National Institute for Health and Clinical Excellence (NICE) guidelines recommends performance of ECG for all patients with cardiac chest pain. Additionally, chest x-rays in patients with suspected congestive heart failure, aortic dissection, aortic aneurysm, valvular heart disease, pericardial disease. However, the guidelines recommend exercise testing in low and intermediate risk patients only after they have been screened for high risk features and other indications for hospital admission.
NICE Guidelines for the Management of Patients with Chest Pain (DO NOT EDIT)[1]
“ |
Key Priorities for Implementation in Patients with Acute Chest Pain
Key Priorities for Implementation in Patients with Stable Chest Pain
Providing Information for People with Chest Pain
|
” |
NICE Guidelines for the Management of Patients with Acute Chest Pain (DO NOT EDIT)[1]
Investigation and diagnosis of acute chest pain in hospital
Assessment of acute chest pain in hospital
| |||||||||||||||||||||||||||||||||||||||||||||||||
Normal resting ECG or non-diagnostic | ECG changes consistent with NSTEMI | ECG changes consistent with STEMI | |||||||||||||||||||||||||||||||||||||||||||||||
Low risk patient with undetectable hs-troponin level: Reassurance, discharge | Consider ACS by clinical judgment even in the presence of normal ECG
| NSTEMI, ACS Guideline follow-up | STEMI Guideline follow-up | ||||||||||||||||||||||||||||||||||||||||||||||
hs-troponin concentration on arrival and at 3 hours bellow the cut-off measurement: Low risk patient, discharge | hs-troponin concentration on arrival and at 3 hours higher than cut-off measurement | Diagnostic criteria for MI | |||||||||||||||||||||||||||||||||||||||||||||||
Yes | NO
| ||||||||||||||||||||||||||||||||||||||||||||||||
The above table adopted from 2016 NICE Guideline |
---|